Emulate Inc. closes $82M Series E to fund expansion of ‘organ-on-a-chip’ products
TechCrunch
SEPTEMBER 7, 2021
This most recent Series E round, led by Northpond Ventures and Perceptive Advisors, is part of Emulate’s plan to invest more heavily in R&D, and create specific organ-on-a-chip applications that they’ve honed in on through conversations with drug companies. There is evidence the company has worked closely with the FDA in the past.
Let's personalize your content